|
EU RISK
ASSESSMENTS OF BFRs
- DecaBDE
- OctaBDE
- PentaBDE
- HBCD
- TBBPA
DecaBDE
Overall information and status
Relevant documents
1. Overall information & status
In May 2004 the EU Competent Authorities officially
closed the scientific assessment of decabromodiphenyl ether (DecaBDE)
with no restrictions due to the lack of risks identified for
the use of this substance. This chemical is used as a flame retardant
in textile backcoating in furniture in some EU countries such as
Ireland and the UK to comply with more stringent fire safety requirements
than exist elsewhere in Europe, and in the housings of computers
as well as in other electrical and electronic applications.
Although not being classified in the EU as a dangerous substance,
in 1994 the European Commission Regulation 1179/94 listed DecaBDE
in the Priority List 1 and designated the UK government as the Member
State rapporteur for the environmental assessment and the French
government for the human health aspect.
After 10 years of scientific research, both the environment and
human risk assessment reports concluded that there is no significant
risk on these areas. On that basis, the EU Competent Authorities
agreed on 26 May 2004 to finalise the risk assessment with no restrictions
in the use of Deca-BDE. In upcoming months industry will develop,
with the French authorities, an independent biomonitoring program
and, in relation to this program, a neurotoxicity study since a
previous study had been declared invalid for risk assessment purposes.
The EU Competent Authorities also agreed during the same meeting
that issues relating to the environmental findings of Deca-BDE in
Europe should be addressed by the initiation of a voluntary industry
monitoring programme. This will be complemented by a further voluntary
programme of industrial emissions control in partnership with Deca-BDE
user industries in Europe.
The first set of Codes of Practices for the use of Deca-BDE by both
the plastics and the textiles industry were developed in the United
Kingdom in September 2004. In the
near future similar Codes of Practices will be developed, in cooperation
with user industries, in other EU Member States such as Belgium,
France, Italy, Germany etc.
Click here for the brochure “Voluntary
emissions control action programme – Greening the textiles
supply chain” .
The monitoring and emissions control programmes provide an
unprecedented level of environmental & health protection for
a chemical whose comprehensive risk assessment has not identified
a risk. The details of these programmes will also involve close
consultation with EU Member State technical experts.
The European Commission Scientific Committee on Health and Environmental
Risks (SCHER) adopted an Opinion in March 2005 on the Environmental
Risk Assessment of Deca-BDE. The Opinion stated that the risk
assessment had been “well done”. Both the European Commission
and the UK government, which led the environmental risk assessment,
have made clear that the SCHER opinion provided no new evidence
demonstrating a risk from Deca-BDE, and that the calls made in the
Opinion for risk reduction measures to address the low levels of
Deca-BDE found in some environmental studies are already being addressed
by the industry’s monitoring and emissions control programmes
developed in conjunction with the EU authorities.
On 16 June 2005 the EU Competent Authorities noted progress on all
the programmes. It was also decided that a format for industry to
report progress on the emissions reduction programme to future Competent
Authority meetings will be developed by the European Commission
and the UK.
A consolidated risk assessment text is expected to be published
shortly by the European
Chemicals Bureau.
DecaBDE is the flame retardant with the most scientific data proving its compatibility in terms of human health, low and manageable risks for the environment and its tremendous contribution to society in terms of fire safety.
DecaBDE Risk Assessment conclusions were published in the Official Journal on 29 May. Please click here to access the document:
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2008:131:0007:0012:EN:PDF
Please
click here for more information on the regulations referring to
DecaBDE.
2. Relevant documents
- Risk Assessment report
(to be published soon)
- SCHER
Scientific Opinion on the Environmental Risk Assessment of Deca-BDE
- EBFRIP
press release on EU Scientific Opinion on the EU risk assessment
of DecaBDE
- Voluntary
emissions control action programme – greening the textiles
supply chain
- UK
Code of Practice for the use of Deca-BDE in plastics
- UK
Code of Practice for the use of Deca-BDE in textiles
- Press
release on launch by the Utrecht University of the human bio-monitoring
programme to assess levels and trends of Deca-BDE
- Press
release of the Netherlands Institute for Fisheries Research-RIVO
on the European environmental monitoring of Deca-BDE
OctaBDE
Overall information and status
Relevant documents
1. Overall
information & Status
The EU finalised the risk assessment of octabromodiphenyl
ether (OctaBDE) in 2002. This chemical is mainly used as a flame
retardant in plastics for electrical and electronic equipment and
in comparison to DecaBDE, is very much a minor flame retardant.
Although not being classified in the EU as a dangerous
substance, in 1994 the European Commission Regulation 1179/94 listed
OctaBDE in the Priority List 1 and designated the UK government
as the Member State rapporteur for the environmental assessment
and the French government for the human health aspect.
The risk assessment identified no risks to the
aquatic, terrestrial or atmospheric environments. The environment
risk assessment stated also a need for further information and/or
testing on the potential risks of secondary poisoning and of degradation.
As regards human health, the risk assessment concluded that there
is no risk through direct exposure to OctaBDE in consumer products.
The human health risk assessment requested nevertheless further
information and/or testing regarding concerns about impacts of repeated
worker dermal and inhalation exposure and about indirect exposure
via the environment.
The Risk Assessment of OctaBDE indicated to Member
States to consider risk reduction measures as it considered that
there was a high level of uncertainty associated to the potential
risks identified in comparison to the level of information available
at that stage. The Member States decision was formalised by the
publication of a EU Commission Recommendation on the results of
the OctaBDE risk assessment and in view of the Risk Reduction Strategy
presented by the United Kingdom. The Commission Recommendation requested
marketing and use restrictions for OctaBDE.
2. Relevant
documents
- Risk
Assessment Report, July 2002
- CSTEE opinion OctaBDE Risk
Assessment, October 2002
- Risk Reduction Strategy,
Final Report June 2002
- European
Commission Recommendation on the OctaBDE RRS, September 2002
PentaBDE
Overall information and status
procedure
Relevant documents
1. Overall
information & status procedure
The EU finalised the risk assessment of diphenyl
ether, pentabromo derivative (PentaBDE) in 2000.
In 2000 the European Commission Regulation 2268/95
listed PentaBDE in the Priority List 2 and designated the United
Kingdom government as the Member State rapporteur for the risk assessment.
The risk assessment identified no risks to the
aquatic, terrestrial or atmospheric environments. The environment
risk assessment stated also a need for further information and/or
testing on the potential risks of secondary poisoning resulting
for biaccumulation. As regards human health, the risk assessment
concluded that there were no risks through direct exposure to PentaBDE
in consumer products. The human health risk assessment requested
nevertheless further information and/or testing regarding occupational
exposure and potential presence of traces of this substance in human
breast milk.
The uncertainties arising from the conclusions
of the risk assessment, in particular concerning the bioaccumulative
nature of PentaBDE and its potential risk for children through breast
milk decided Member States to implement a Risk Reduction Strategy
for PentaBDE which was followed by a European Commission Recommendation
requesting marketing and use restrictions.
Please
click here for more information on the regulations referring to
PentaBDE as the conclusions presented above become irrelevant with
the EU ban on PentaBDE
2. Relevant
documents
- PentaBDE
Risk Assessment Report, August 2000
- CSTEE Opinion
on Environmental part, February 2000
- CSTEE
Opinion on Health part, June 2000
- PentaBDE Risk Reduction
Report
- European Commission
Recommendation on the PentaBDE RRS, March 2001
HBCD
Overall information and status
procedure
Relevant documents
1.
Overall information & Status procedure
The EU has recently started the scientific assessment
of the Hexabromocyclododecane (HBCD). This chemical is mainly used
to in Expanded and Extruded Polystyrene (EPS and XPS) for thermal
insulation foams, in building and construction. HBCD is also applied
in the backcoating of textiles, mainly for upholstery furniture.
Although not being classified in the EU as a dangerous
substance, in 2000 the European Commission Regulation 2268/95 listed
HBCD in the Priority List 2 and designated the Swedish government
as the Member State rapporteur for the risk assessment.
The rapporteur is expected to issue a draft Risk
Assessment Report during July 2003 with the intention of adopting
the final report before the end of the year.
Please click
here for more information on the regulations referring to HBCD
2. Relevant documents
BSEF factsheet HBCD 2008.pdf
TBBPA
Overall information and status
procedure
Relevant documents
1. Overall information & status procedure
Tetrabromobisphenol A (TBBPA) is the main flame retardant used for printed circuit boards to improve fire safety.
TBBPA environmental Risk Assessment was completed in June 2007. No concern was identified in practice by the risk assessment for TBBPA use for the production of printed circuit board laminates.
Emissions of TBBPA when added to ABS plastics can cause local and low risk at plant level for surface water, sediment and soil.
Risks were identified if sludge containing TBBPA is applied to agricultural soil. In practice, however, this does not happen as sludge from user sites in Europe is sent to incineration and controlled landfills.
The human health part of the risk assessment has concluded that TBBPA does not present any risk to human health.
BSEF believes that most of the risks identified for additive application are manageable through a Voluntary Emissions Control Action Programme (VECAP). To date, 100% of TBBPA additive customers in Europe have already committed to control and reduce their emissions.
The UK has drafted a Risk Reduction Strategy (RRS) to address the local risk for soil, water and sediment identified by the Risk Assessment when TBBPA is used as an additive, The RRS recommended a measure to reduce emissions at production plants (IPPC - Integrated Pollution Prevention and Control Directive) as an appropriate tool to control the risk identified at an ABS compounding site in Europe. This plant recently closed.
On 23 October 2007, the RRS for TBBPA was discussed at EU level. The EU RRS officials approved the above proposed strategy.
On 15 January, the European Commission’s Scientific Committee SCHER adopted its opinion on the environmental part of the TBBPA Risk Assessment, which was concluded in June 2007. The SCHER Opinion considers that “the environmental part of the risk assessment of tetrabromobisphenol-A is in general of good quality”.
The European Commission will conclude the whole RA process by publishing in the Official Journal a Commission Decision consisting of the RA conclusions and the RRS.
SCHER - the Scientific Committee on Health and Environmental Risks – is in charge of questions relating to examinations of toxicity and ecotoxicity of chemicals, biochemicals and biological compounds for human health and the environment
2.
Relevant documents
- For the Factsheet on TBBPA go to:
http://www.bsef.com/publications/BSEF_factsheet_TBBPA_160108.pdf
- For more information on the SCHER’s review of the human health risk assessment go to:
http://www.bsef.com/newsmanager/uploads/ebfrip_statement_scher_opinion_tbbpa_oct_05.pdf
- To see the full final human health risk assessment:
http://www.bsef.com/newsmanager/uploads/final_tbbpa_human_health_report.pdf
- For more information on the SCHER’s review of the Environment risk assessment go to: http://ec.europa.eu/health/ph_risk/committees/04_scher/docs/scher_o_071.pdf
- For the press release on the closure of the RA go to: http://www.bsef.com/newsmanager/uploads/statement_on_ra_conclusion__18sept07.pdf
- IPC White Paper
|